3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
35
Carcinoma, Non-Small-Cell Lung
27
Breast Neoplasms
15
Lung Neoplasms
13
Neoplasm Metastasis
12
Triple Negative Breast Neoplasms
11
Neoplasms
10
Colorectal Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Head and Neck Neoplasms
4
Carcinoma, Pancreatic Ductal
4
Stomach Neoplasms
3
Neoplasms by Site
3
Gastrointestinal Neoplasms
3
Carcinoma
3
Adenocarcinoma
3
Vaccinia
2
Rectal Neoplasms
2
Ovarian Neoplasms
2
Neoplasms by Histologic Type
2
Gallbladder Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Brain Neoplasms
2
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Thymoma
1
Interventions
Gemcitabine
33
Cisplatin
22
pembrolizumab
21
Magnetic Resonance Spectroscopy
18
Specimen Handling
16
durvalumab
12
Mitomycin
10
enfortumab vedotin
9
avelumab
9
Nivolumab
9
Cystoscopy
9
Fluorouracil
8
Carboplatin
8
Radiation
7
Cystectomy
7
Radiotherapy
6
Immunoglobulin G
6
Docetaxel
6
Disulfides
6
atezolizumab
5
Transurethral Resection of Bladder
5
Mitozytrex
5
Biopsy
5
tremelimumab
4
sacituzumab govitecan
4
erdafitinib
4
dehydroftorafur
4
Standard of Care
4
Platinum
4
1,2-diaminocyclohexaneplatinum II citrate
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
130-nm albumin-bound paclitaxel
×
90 days
×
Clear all
No trials found.